The MRA Young Investigator Award funds early career scientists for innovative translational research to improve melanoma prevention, diagnosis, staging, and treatment.
Funder: Melanoma Research Alliance
Due Dates (Anticipated): September 2026: Eligibility checklist and biosketch (Young Investigator Award) | November 2026: Full proposal (Young Investigator Award)
Funding Amounts: Funding details for the Young Investigator Award are set by the annual RFP; recent cycles have supported substantial multi-year awards.
Summary: Supports early career scientists pursuing innovative translational research to advance melanoma prevention, diagnosis, staging, and treatment.
Key Information: Mentorship from a senior investigator is required; applicants must be within five years of their first faculty appointment.
The Young Investigator Award from the Melanoma Research Alliance (MRA) is designed to attract and support early career scientists with novel ideas in melanoma research. The focus is on innovative, translational projects that can advance the prevention, diagnosis, staging, and treatment of melanoma in the near and intermediate future. The program emphasizes mentorship and the development of the next generation of melanoma researchers.